|
Email:
|
martina.chripkova@upjs.sk | |
|
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/martina.chripkova | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
UFR
-
Department of Pharmacology
|
|
|
Office:
|
MA3O12 | |
|
Phone:
|
+421 55 234 3252 | |
|
ORCID ID:
|
0000-0001-7486-8249 |
|
Profile courses
|
|
Pharmacology 2 - General Medicine, I.+II. degree
|
|
Pharmacology 2 - Dentistry, Dental Medicine, I.+II. degree
|
|
Selected publications
|
|
V3: Zigová M, Miškufová V, Budovská M, Michalková R, Mojžiš J. Exploring the Antiproliferative and Modulatory Effects of 1-Methoxyisobrassinin on Ovarian Cancer Cells: Insights into Cell Cycle Regulation, Apoptosis, Autophagy, and Its Interactions with NAC. Molecules. 2024; 29(8):1773, (IF=4,6; Q2) cit. 1x |
|
O3: Zigová M, Michalková R, Mojžiš J. Anticancer Potential of Indole Phytoalexins and Their Analogues. Molecules. 2024, 19;29(10):2388. (IF=4,6; Q2) cit. 1x |
|
V3: Balážová Ľ, Kurhajec S, Kello M, Bedlovičová Z, Zigová M, Petrovová E, Beňová K, Mojžiš J, Eftimová J. Antiproliferative Effect of Phellodendron amurense Rupr. Based on Angiogenesis. Life (Basel). 2022, 12(5):767. (IF=3,2; Q2), cit. 9x |
|
V3: Čižmáriková M, Michalková R, Mirossay L, Mojžišová G, Zigová M, Bardelčíková A, Mojžiš J. Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. Biomolecules. 2023;13(11):1653. (IF=5,5; Q1), cit. 15x |
|
V3: Kamal Z, Al-Amgad Z, Zigo F, Farkašová Z, Zigová M (korešpondenčný autor), Adel M, Alaa H, Rehan IF,Heavy consumption of garlic (Allium sativum) exert nephro- and pulmonary toxicity at maternal and embryonic level in the Albino rats, Journal of applied animal research, 2023, 51 (1), pp.776-788. (IF =1,4; Q3), cit. 1x |
|
Selected projects
|
|
VEGA 1/0103/16: Brasinín a jeho deriváty ako potenciálne protinádorové liečivá. 2016-2019. Principal investigator in 2016: MVDr. Martina Zigová, PhD. |
|
VEGA 1/0653/19: Sekundárne metabolity lišajníkov: sľubné modulátory nádorového mikroprostredia. 2019- 2022. Principal investigator: RNDr. Martin Kello, PhD. |
|
VEGA 1/0446/22: Štúdium chalkónov v kontexte ich pôsobenia na membránové transportéry zodpovedné za liekovú rezistenciu. 2022-2025. Principal investigator: doc. MUDr. Martina Čižmariková, PhD.
|
|
VEGA 1/0498/23 Modulácia nádorového mikroprostredia rakoviny prsníka sekundárnymi metabolitmi lišajníkov: in vitro štúdia. 2023-2026 Zodpovedný riešiteľ: RNDr. Martin Kello, PhD. |
|
International mobilities and visits
|
|
Mario Negri Institute for Pharmacological Research, Department of Oncology, Milano, Italy, 01/05/13 - 31/7/13, Erasmus internship
|
